Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Group B coxsackieviral (CVB) infection commonly causes viral myocarditis. Mice are protected from CVB3 myocarditis by gene-targeted knockout of p56Lck(Lck), the Src family kinase (Src) essential for T cell activation. Extracellular signal-regulated kinase 1 and 2 (ERK-1/2) can influence cell function downstream of Lck. Using T cell lines and neonatal cardiac myocytes we investigated the role of ERK-1/2 in CVB3 infection. In Jurkat T cells ERK-1/2 is rapidly activated by CVB3; but, this response is absent in Lck-negative JCaM T cells. Inhibition of ERK-1/2 with UO126 reduced CVB3 titers in Jurkat cells, but not in JCaM cells. In cardiac myocytes CVB3 activation of ERK-1/2 is blocked by the Src inhibitor PP2. In addition, viral production in myocytes is decreased by Src or ERK-1/2 inhibition. In vitro, in both immune and myocardial cells, ERK-1/2 is activated by CVB3 downstream of Lck and other Src's and is necessary for efficient CVB3 replication. In vivo, following CVB3 infection, ERK-1/2 activation is evident in the myocardium. ERK-1/2 activation is intense in the hearts of myocarditis-susceptible A/J mice. In contrast, significantly less ERK-1/2 activation is found in the hearts of myocarditis-resistant C57BL/6 mice. Therefore, the ERK-1/2 response to CVB3 infection may contribute to differential host susceptibility to viral myocarditis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This leads to the activation of extracellular signal-regulated kinases 1 and 2 (ERK-1/2), subsequently promoting viral replication inside leukocytes, mainly T cells [66].”
From Viral meningitis: an overview (2021) · cites this paper as [66]
Citations
Cites
The mitogen-activated protein kinase signal transduction pathway
Davis, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82362-6 · Cited by 2,139
Boulton, T. G., Nye, S. H., Robbins, D. J., Ip, N. Y., Radzlejewska, E., Morgenbesser, S. D., DePinho, R. A., Panayotatos, N., Cobb, M. H., & Yancopoulos, G. D. (1991) · Cell · doi:10.1016/0092-8674(91)90098-j · Cited by 1,897
Straus, D. (1992) · Cell · doi:10.1016/0092-8674(92)90428-f · Cited by 1,034 · cited 1×
“T cell stimulation by antigen or anti-TCR Ab’s is characterized by a rise of intracellular tyrosine protein phosphorylation, which is dependent upon Lck (9, 10).”
BackgroundInsulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II
Sturgill, T. W., Ray, L. B., Erikson, E., & Maller, J. L. (1988) · Nature · doi:10.1038/334715a0 · Cited by 1,017
Gutkind, J. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.1839 · Cited by 812 · cited 5×
“RasGAP is cleaved at 6 hours after infection, possibly activating the Ras/MAPK pathway (24).”
BackgroundInfluentialParker, T. G., Packer, S. E., & Schneider, M. D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114466 · Cited by 374 · cited 1×
“Neonatal mouse cardiac myocyte cultures were prepared as described previously (16), with modifications.”
MethodInvolvement of T Lymphocytes in the Pathogenesis of Coxsackie Virus B3 Heart Disease
Woodruff, J. F., & Woodruff, J. J. (1974) · The Journal of Immunology · doi:10.4049/jimmunol.113.6.1726 · Cited by 315 · cited 2×
“Investigations using murine models have demonstrated that both the T lymphocyte response to viral infection and direct CVB-mediated injury are important in the development of myocarditis following infection with CVB3 (4, 5).”
BackgroundMethodInfluentialT Cell Activation Induces Rapid Tyrosine Phosphorylation of a Limited Number of Cellular Substrates
Hsi, E. D., Siegel, J. N., Minami, Y., Luong, E. T., Klausner, R. D., & Samelson, L. E. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81696-9 · Cited by 244 · cited 1×
“T cell stimulation by antigen or anti-TCR Ab’s is characterized by a rise of intracellular tyrosine protein phosphorylation, which is dependent upon Lck (9, 10).”
BackgroundThe Src family of tyrosine protein kinases in hemopoietic signal transduction
Bolen, J. B., Rowley, R. B., Spana, C., & Tsygankov, A. Y. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.15.1281458 · Cited by 215
Opavsky, M. A., Penninger, J., Aitken, K., Wen, W.-H., Dawood, F., Mak, T., & Liu, P. (1999) · Circulation Research · doi:10.1161/01.res.85.6.551 · Cited by 194 · cited 4×
“Gene-targeted knockout of both CD4+ and CD8+ T cells or the T cell receptor β+ (TCR-β) T cells results in minimal heart pathology following CVB3 infection (6).”
BackgroundMethodSelf-citation
Research works printed but not linked: 4
- Woodruff, 1980, Am J Pathol, 101, 427
- Liu, 1996, Can J Cardiol, 12, 935
- Chow, 1992, Lab Invest, 66, 24
- Chow, 1991, Lab Invest, 64, 55
Cited by
The Science Underlying COVID-19: Implications for the Cardiovascular System
Liu, P. P., Blet, A., Smyth, D., & Li, H. (2020) · Circulation · doi:10.1161/circulationaha.120.047549 · Cited by 800
Self-citationMolecular Mimicry, Bystander Activation, or Viral Persistence: Infections and Autoimmune Disease
Fujinami, R. S., von Herrath, M. G., Christen, U., & Whitton, J. L. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.1.80-94.2006 · Cited by 679
Fung, G., Luo, H., Qiu, Y., Yang, D., & McManus, B. (2016) · Circulation Research · doi:10.1161/circresaha.115.306573 · Cited by 444
Molecular Biology and Pathogenesis of Viral Myocarditis
Esfandiarei, M., & McManus, B. M. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.151534 · Cited by 379
Molecular Biology and Pathogenesis of Viral Myocarditis
Esfandiarei, M., & McManus, B. M. (2007) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.3.121806.151534 · Cited by 256
Coxsackievirus B3 Replication and Pathogenesis
Garmaroudi, F. S., Marchant, D., Hendry, R., Luo, H., Yang, D., Ye, X., Shi, J., & McManus, B. M. (2015) · Future Microbiology · doi:10.2217/fmb.15.5 · Cited by 228
Frantz, S., Falcao-Pires, I., Balligand, J.-L., Bauersachs, J., Brutsaert, D., Ciccarelli, M., Dawson, D., de Windt, L. J., Giacca, M., Hamdani, N., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1138 · Cited by 184
Src protein tyrosine kinase family and acute inflammatory responses
Okutani, D., Lodyga, M., Han, B., & Liu, M. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00261.2005 · Cited by 171
“The activation of lymphocytes and consequently excessive inflammatory responses are the major cause of death induced by CVB3; Lck and related signals play an essential role that controls the replication and pathogenicity of this virus.”
BackgroundInfluentialKohil, A., Jemmieh, S., Smatti, M. K., & Yassine, H. M. (2021) · Archives of Virology · doi:10.1007/s00705-020-04891-1 · Cited by 164
“This leads to the activation of extracellular signal-regulated kinases 1 and 2 (ERK-1/2), subsequently promoting viral replication inside leukocytes, mainly T cells [66].”
BackgroundProtective Role for Interferon-β in Coxsackievirus B3 Infection
Deonarain, R., Cerullo, D., Fuse, K., Liu, P. P., & Fish, E. N. (2004) · Circulation · doi:10.1161/01.cir.0000136824.73458.20 · Cited by 161
Self-citationAndrade, A. A., Silva, P. N. G., Pereira, A. C. T. D. C., Sousa, L. P., Ferreira, P. C. P., Gazzinelli, R. T., Kroon, E. G., Ropert, C., & Bonjardim, C. A. (2004) · Biochemical Journal · doi:10.1042/bj20031375 · Cited by 154
Si, X., Wang, Y., Wong, J. T., Zhang, J., McManus, B. M., & Luo, H. (2007) · Journal of Virology · doi:10.1128/jvi.02028-06 · Cited by 140
“We and others have shown that activation of MAPKs following CVB3 infection plays a critical role in the regulation of viral replication (15, 19, 25).”
BackgroundShi, Y., Fukuoka, M., Li, G., Liu, Y., Chen, M., Konviser, M., Chen, X., Opavsky, M. A., & Liu, P. P. (2010) · Circulation · doi:10.1161/circulationaha.109.893248 · Cited by 126
Self-citationRNA viruses and the mitogenic Raf/MEK/ERK signal transduction cascade
Pleschka, S. (2008) · Biological Chemistry · doi:10.1515/bc.2008.145 · Cited by 130
“Treatment of cells with the selective MEK inhibitor U0126 significantly inhibited CVB3 progeny release and decreased virus protein production (Luo et al., 2002; Opavsky et al., 2002).”
BackgroundSi, X., McManus, B. M., Zhang, J., Ji, Y., Cheung, C., Esfandiarei, M., Suarez, A., Morgan, A., & Luo, H. (2005) · Journal of Virology · doi:10.1128/jvi.79.13.8014-8023.2005 · Cited by 115
“Several signaling proteins, such as the extracellular signal-regulated kinase 1 and 2 (ERK1/2) (14, 26, 37, 43) and protein kinase B/Akt (PKB/Akt) (21), are activated following CVB3 infection, and activation of these signaling proteins is important to successfully complete CVB3 life cycle.”
BackgroundStress-Activated Protein Kinases Are Involved in Coxsackievirus B3 Viral Progeny Release
Si, X., Luo, H., Morgan, A. J., Zhang, J., Wong, J. T., Ji, Y., Esfandiarei, M., Gao, G., Cheung, C., & McManus, B. M. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.13875-13881.2005 · Cited by 113
“We and others have shown that CVB3 replication results in activation of cell survival pathways mediated by activation of ERK1/2 (13, 29, 35) and PI3K/AKT (15) and in activation of cell death pathways mediated by cytochrome c release and caspase-3 cleavage (5, 13, 30, 52).”
BackgroundInfluentialPhosphorylation of PI3K/Akt and MAPK/ERK in an early entry step of enterovirus 71
Wong, W., Chen, Y.-Y., Yang, S., Chen, Y.-L., & Horng, J. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.04.076 · Cited by 110
“These pathways may be induced by direct virus–receptor binding, such as that seen in the HIV activation of ERK (Popik et al., 1998), or by exposure to a viral protein, for example the hepatitis C virus core protein (Fukuda et al., 2001) and the HIV Tat protein (Rusnati et al., 2001).”
BackgroundSzalay, G., Sauter, M., Haberland, M., Zuegel, U., Steinmeyer, A., Kandolf, R., & Klingel, K. (2009) · Circulation Research · doi:10.1161/circresaha.109.193805 · Cited by 88
Ubiquitination Is Required for Effective Replication of Coxsackievirus B3
Si, X., Gao, G., Wong, J. T., Wang, Y., Zhang, J., & Luo, H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002585 · Cited by 93
“family, is an important human pathogen associated with various diseases, including myocarditis, aseptic meningitis, pancreatitis and possibly insulin-dependent diabetes. We and others have shown that CVB3 infection leads to activation of several intracellular signaling pathways”
BackgroundLang, C., Sauter, M., Szalay, G., Racchi, G., Grassi, G., Rainaldi, G., Mercatanti, A., Lang, F. J. W., Kandolf, R., & Klingel, K. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0249-3 · Cited by 83
“Besides Smad molecules, the Ras/MEK/ERK cascade as well as the JNK-dependent pathway was found to contribute to TGF-β-dependent stimulation of CTGF expression in fibroblasts [14, 27, 28].”
BackgroundStructural basis for the activity of the RSK-specific inhibitor, SL0101
Smith, J. A., Maloney, D. J., Hecht, S. M., & Lannigan, D. A. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.03.087 · Cited by 74
Coxsackievirus B3 Infection Induces cyr61 Activation via JNK To Mediate Cell Death
Kim, S.-M., Park, J.-H., Chung, S.-K., Kim, J.-Y., Hwang, H.-Y., Chung, K.-C., Jo, I., Park, S.-I., & Nam, J.-H. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13479-13488.2004 · Cited by 70
Coyne, C. B., Bozym, R. A., Morosky, S., Hanna, S. L., Mukherjee, A., Tudor, M., Kim, K., & Cherry, S. (2011) · Cell Host and Microbe · doi:10.1016/j.chom.2011.01.001 · Cited by 78
“, 1999), and enhanced ERK1/2 activation has been detected in cardiac tissue from CVBinfected mice (Opavsky et al., 2002).”
BackgroundThe immunoproteasome‐specific inhibitor ONX 0914 reverses susceptibility to acute viral myocarditis
Althof, N., Goetzke, C. C., Kespohl, M., Voss, K., Heuser, A., Pinkert, S., Kaya, Z., Klingel, K., & Beling, A. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708089 · Cited by 73
“Therefore, viral titers of heart tissue usually peaking around 4–6 days after initial virus inoculation (Opavsky et al, 2002) were determined throughout disease course.”
BackgroundResultShen, Y., Xu, W., Chu, Y.-W., Wang, Y., Liu, Q.-S., & Xiong, S.-D. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12548-12556.2004 · Cited by 67
“Recently, the ERK pathway has been implicated in the regulation of viral gene expression and replication for human cytomegalovirus (17), simian virus 40 (40), human immunodeficiency virus type 1 (16, 44), influenza virus (11), and CVB3 (33).”
BackgroundActivation of Transcription Factors AP-1 and NF-κB in Murine Chagasic Myocarditis
Huang, H., Petkova, S. B., Cohen, A. W., Bouzahzah, B., Chan, J., Zhou, J.-N., Factor, S. M., Weiss, L. M., Krishnamachary, M., Mukherjee, S., et al. (2003) · Infection and Immunity · doi:10.1128/iai.71.5.2859-2867.2003 · Cited by 65
Self-citationAutoimmune Myocarditis, Valvulitis, and Cardiomyopathy
Myers, J. M., Fairweather, D., Huber, S. A., & Cunningham, M. W. (2013) · Current Protocols in Immunology · doi:10.1002/0471142735.im1514s101 · Cited by 63
“…mice (Eriksson et al., 2001), CD1d-deficient mice (Huber et al., 2003), type 1 or type II IFN–deficient mice (Wessely et al., 2001), PD1-deficient MRL mice (Wang et al., 2010), T cell receptor β chain–deficient mice (Opavsky et al., 1999), and p56-deficient mice (Opavsky et al., 2002).”
BackgroundYuan, J., Zhang, J.-Q., Wong, B. W., Si, X., Wong, J. T., Yang, D., & Luo, H. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401652 · Cited by 64
“Previous studies have shown that Src family tyrosine kinases are activated early after CVB3 infection.(15,16) To determine”
BackgroundMyocarditis, Microbes and Autoimmunity
Whitton, J. L., & Feuer, R. (2004) · Autoimmunity · doi:10.1080/08916930410001713089 · Cited by 55
“Infection of T and B cells by CVB has been demonstrated by several laboratories, and their susceptibility to infection may be dependent upon their activation status; mice deficient in the T cell activation enzyme p56 support only low levels of CVB production, and are relatively resistant to CV-mediated myocarditis;([8…”
BackgroundEsfandiarei, M., Suarez, A., Amaral, A. P., Si, X., Rahmani, M., Dedhar, S., & McManus, B. M. (2006) · Circulation Research · doi:10.1161/01.res.0000237022.72726.01 · Cited by 50
Coxsackievirus Type B3 Is a Potent Oncolytic Virus against KRAS-Mutant Lung Adenocarcinoma
Deng, H., Liu, H., de Silva, T., Xue, Y. C., Mohamud, Y., Ng, C. S., Qu, J., Zhang, J., Jia, W. W.-G., Lockwood, W. W., et al. (2019) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2019.07.003 · Cited by 50
“Previous in vitro and in vivo evidence has demonstrated that CVB3 replication relies largely on the activation of oncogenic signaling pathways, among which the ERK1/2 signaling is the best characterized and proven to be the most important signaling pathway hijacked by CVB3 for effective replication.(28,29) To determin…”
BackgroundSrc-family Protein Tyrosine Kinases: A promising target for treating Cardiovascular Diseases
Zhai, Y., Yang, J., Zhang, J., Yang, J., Li, Q., & Zheng, T. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.49241 · Cited by 47
Cunningham, K., Chapman, N. M., & Carson, S. D. (2003) · Virus Research · doi:10.1016/s0168-1702(03)00044-3 · Cited by 41
Yuen, S., Smith, J. M., Caruso, L., Balan, M., & Opavsky, M. A. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.02.011 · Cited by 41
Self-citationChen, Z., Li, Y., Liu, Y., Tang, A., Li, X., Zhang, J., & Yang, Z. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1825-1 · Cited by 42
“The possible mechanisms include activation of caspase-3 [12], phosphorylation, and activation of the extracellular signalregulated kinase (ERK1/2) [13], activation of protein kinaseB/AKT(PKB/AKT) [14].”
BackgroundMarchant, D., Sall, A., Si, X., Abraham, T., Wu, W., Luo, Z., Petersen, T., Hegele, R. G., & McManus, B. M. (2009) · Journal of General Virology · doi:10.1099/vir.0.005868-0 · Cited by 38
“, 2002) and in vivo (Opavsky et al., 2002), but the precise mechanism of activation has not been elucidated.”
Patel, H., Madanieh, R., Kosmas, C. E., Vatti, S. K., & Vittorio, T. J. (2015) · Clinical Medicine Insights Cardiology · doi:10.4137/cmc.s19703 · Cited by 37
Genome–environment interactions in the molecular pathogenesis of dilated cardiomyopathy
Poller, W. C., Kühl, U., Tschöepe, C., Pauschinger, M., Fechner, H., & Schultheiss, H.-P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0664-2 · Cited by 41
Antiviral effects of pan-caspase inhibitors on the replication of coxsackievirus B3
Martin, U., Jarasch, N., Nestler, M., Rassmann, A., Münder, T., Seitz, S., Zell, R., Wutzler, P., & Henke, A. (2007) · APOPTOSIS · doi:10.1007/s10495-006-0015-y · Cited by 35
Baig, E., & Fish, E. N. (2008) · Antiviral Therapy · doi:10.1177/135965350801300306 · Cited by 33
“Different strains of mice are differentially susceptible to CVB3-induced disease [37,38].”
BackgroundDevelopment of Group B Coxsackievirus as an Oncolytic Virus: Opportunities and Challenges
Liu, H., & Luo, H. (2021) · Viruses · doi:10.3390/v13061082 · Cited by 41
Caruso, L., Yuen, S., Smith, J. M., Husain, M., & Opavsky, M. A. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.01.022 · Cited by 34
Self-citationCoxsackievirus-induced myocarditis: new trends in treatment
Liu, Z., Ji, Y., Yanagawa, B., Qiu, D., McManus, B. M., & Yang, D. (2005) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.3.4.641 · Cited by 36
Lim, B., Nam, J., Gil, C.-O., Yun, S., Choi, J., Kim, D., & Jeon, E. (2005) · Virus Research · doi:10.1016/j.virusres.2005.04.018 · Cited by 28
Dissecting mechanisms of innate and acquired immunity in myocarditis
Ayach, B., Fuse, K., Martino, T. A., & Liu, P. J. (2003) · Current Opinion in Cardiology · doi:10.1097/00001573-200305000-00001 · Cited by 30
Self-citationLiu, X., Hao, J., Wei, P., Zhao, X., Lan, Q., Ni, L., Chen, Y., Bai, X., Ni, L., & Dong, C. (2022) · Science Advances · doi:10.1126/sciadv.abo4577 · Cited by 37
Sharma, V., Goessling, L. S., Brar, A. K., Joshi, C. S., Mysorekar, I. U., & Eghtesady, P. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.017995 · Cited by 25
“49 Our viral quantification studies suggest the placenta does perform a superb job at filtering much of the viral wave.”
The human fatty acid synthase: A new therapeutic target for coxsackievirus B3-induced diseases?
Rassmann, A., Henke, A., Jarasch, N., Lottspeich, F., Saluz, H., & Münder, T. (2007) · Antiviral Research · doi:10.1016/j.antiviral.2007.06.011 · Cited by 29
Genetic Determinants of Coxsackievirus B3 Pathogenesis
McManus, B. M., Yanagawa, B., Rezai, N., Luo, H., Taylor, L., Zhang, M., Yuan, J. Y., Buckley, J. D., Triche, T. J., Schreiner, G. F., et al. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb05950.x · Cited by 24
Toll-Like Receptors: Are They Taking a Toll on the Heart in Viral Myocarditis?
Favere, K., Bosman, M., Klingel, K., Heymans, S. R. B., Linthout, S. V., Delputte, P., SUTTER, J. D., Heidbüchel, H., & Guns, P. (2021) · Viruses · doi:10.3390/v13061003 · Cited by 24
“, ERK-1/2 activation, may contribute to differential host susceptibility to viral myocarditis [99].”
BackgroundGruhle, S., Sauter, M., Szalay, G., Ettischer, N., Kandolf, R., & Klingel, K. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-012-0287-z · Cited by 20
“In fact, CVB3 replication is known to be dependent on the activation of the p44/42 MAPK in the host cell and, vice versa, also promotes the activation of the MAPK in the sense of a self-amplification cycle [17, 34, 39].”
BackgroundYoshikawa, T. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-0373 · Cited by 21
Coxsackievirus B3 vaccines: use as an expression vector for prevention of myocarditis
Henke, A., Jarasch, N., & Wutzler, P. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.10.1557 · Cited by 19
Jensen, H. A., Styskal, L. E., Tasseff, R., Bunaciu, R. P., Congleton, J., Varner, J. D., & Yen, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058621 · Cited by 18
“Interestingly, PP2 treatment in both R38+ and R382 results in a decrease of ERK phosphorylation, an effect that has been documented in other cell lines [49,50,51].”
BackgroundDuan, H., Zhu, M. T., Xiong, Q., Wang, Y., Xu, C., Sun, J., Wang, C., Zhang, H., Xu, P., & Peng, Y. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.03.018 · Cited by 20
Chung, J. H., Choi, H. J., Kim, S. Y., Hong, K. S., Min, S. K., Nam, M. H., Kim, C., Koh, Y. H., & Seo, J. B. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-520 · Cited by 20
“We also examined whether ERK-1/2 signaling, which has been shown to play a role in the susceptibility to CVB3-induced myocarditis in mice, was altered [15].”
BackgroundLi, M., Wang, X., Xie, Y., Xie, Y., Zhang, X., Zou, Y., Ge, J., & Chen, R. (2012) · Cardiovascular Pathology · doi:10.1016/j.carpath.2012.06.004 · Cited by 18
“Besides the environmental nutrition factors [14], this insusceptibility has been attributed to the different immune response pattern of C57BL/6 from Balb/c mice [15,16] and different intrinsic signal transduction pathways [17,18].”
BackgroundManipulating Intestinal Immunity and Microflora: An Alternative Solution to Viral Myocarditis?
Qian, Q., Xiong, S., & Xu, W. (2012) · Future Microbiology · doi:10.2217/fmb.12.96 · Cited by 15
“CVB3 could activate ERK downstream of Lck, which is necessary for efficient CVB3 replication and T-cell activation [37].”
BackgroundHwang, H. Y., Kim, J., Lim, J.-Y., Chung, S., Nam, J., & Park, S. I. (2007) · Virus Research · doi:10.1016/j.virusres.2007.05.007 · Cited by 17
Kim, S., Shin, H.-H., Kim, J.-H., Park, J., Jeon, E., & Lim, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031489 · Cited by 14
“signals completely blocked CVB3 replication in HeLa cells [12].”
BackgroundModels of coxsackievirus-B3-induced myocarditis: recent advances
Fairweather, D., & Rose, N. R. (2004) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2004.11.003 · Cited by 16
Beling, A., & Kespohl, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02620 · Cited by 17
“Nevertheless, this finding in B6 mice is in clear contrast to findings made in A/J mice, which exhibit high susceptibility for virus-mediated inflammation of heart tissue (118, 119) and generally present with increased viral burden in the heart.”
ResultJensen, H. A., Bunaciu, R. P., Varner, J. D., & Yen, A. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.03.014 · Cited by 14
Valaperti, A., Nishii, M., Liu, Y., Yang, H. H., Naito, K., Liu, P. P., & Eriksson, U. (2014) · Basic Research in Cardiology · doi:10.1007/s00395-014-0411-3 · Cited by 12
Self-citationWong, J. T., Zhang, J., Si, X., Gao, G., & Luo, H. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.013 · Cited by 12
Klingel, K. (2002) · European Heart Journal Supplements · doi:10.1016/s1520-765x(02)90104-5 · Cited by 12
Viral Infection and Heart Disease: Autoimmune Mechanisms
Afanasyeva, M., & Rose, N. R. (2004) · Elsevier eBooks · doi:10.1016/b978-044451271-0.50025-9 · Cited by 12
Coxsackievirus B3 Activates Macrophages Independently of CAR-Mediated Viral Entry
Mohamud, Y., Lin, J. F. C., Hwang, S. W., Bahreyni, A., Wang, Z. C., & Luo, H. (2024) · Viruses · doi:10.3390/v16091456 · Cited by 9
“Although CVB3 was shown to replicate in distinct immune cell populations, including B and T lymphocytes, it is unclear whether such replication occurs in macrophages [27,28].”
BackgroundThe molecular basis of cardiotropic viral infections
Poller, W. C. (2002) · European Heart Journal Supplements · doi:10.1016/s1520-765x(02)90106-9 · Cited by 9
“[90] and others[91] (also see the article by Liu et al.”
BackgroundThe zinc containing pro-apoptotic protein siva interacts with the peroxisomal membrane protein pmp22
Nestler, M., Martin, U., Hortschansky, P., Saluz, H., Henke, A., & Münder, T. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-9082-6 · Cited by 11
“Activation of ERK1/2 after coxsackievirus infection is also dependent on p56lck [10].”
BackgroundCleavage of Grb2-Associated Binding Protein 2 by Viral Proteinase 2A during Coxsackievirus Infection
Deng, H., Fung, G., Qiu, Y., Wang, C., Zhang, J., Jin, Z., & Luo, H. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00085 · Cited by 7
“Inhibition of this pathway by either chemical inhibitors or a dominant-negative construct significantly decreases the production of viral protein and progeny virion (Luo et al., 2002; Cunningham et al., 2003; Jensen et al., 2013; Opavsky et al., 2002).”
BackgroundMichael, L. H., Taffet, G. E., Entman, M. L., Reddy, A. K., Hartley, C. J., & Frangogiannis, N. G. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382008-2.00011-8 · Cited by 6
Estepa, M., Niehues, M. H., Vakhrusheva, O., Haritonow, N., Ladilov, Y. V., Barcena, M. L., & Regitz‐Zagrosek, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179666 · Cited by 8
Rinkūnaitė, I., Šimoliūnas, E., Alksnė, M., Bartkutė, G., Labeit, S., Bukelskienė, V., & Bogomolovas, J. (2022) · Biomolecules · doi:10.3390/biom12121898 · Cited by 6
Comparison and Analysis on the Existing Single-Herbal Strategies against Viral Myocarditis
Cao, Y., Liu, Y., Zhang, T., Pan, J., Lei, W., & Zhang, B. (2021) · Genetics Research · doi:10.1155/2021/9952620 · Cited by 5
“Under coxsackieviral infection, the viral production in myocytes is reduced by SRC inhibition [87].”
BackgroundYang, K., Zhang, M., Li, D., Yu, Y., Cao, F., & Wan, G. (2024) · European Journal of Inflammation · doi:10.1177/1721727x231223578 · Cited by 4
Liu, P. X., & Baughman, K. L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0398-6.00070-6 · Cited by 6
Self-citationPediatric viral myocarditis: mechanisms, experimental models, and research gaps
Ling, I., Alburquerque, R. A., & Steed, A. L. (2026) · Pediatric Research · doi:10.1038/s41390-026-04845-4 · Cited by 4
Caboxamycin Inhibits Heart Inflammation in a Coxsackievirus B3-Induced Myocarditis Mouse Model
Kim, H. G., Hillman, P. F., Lee, Y.-J., Jeon, H.-E., Lim, B., & Nam, S. (2024) · Viruses · doi:10.3390/v16050677 · Cited by 3
Michael, L. H., Taffet, G. E., Frangogiannis, N. G., Entman, M. L., & Hartley, C. J. (2004) · Elsevier eBooks · doi:10.1016/b978-012336425-8/50066-2 · Cited by 3
Molecular and Cellular Mechanism of Pathogen Invasion into the Central Nervous System: Meningitis
Singh, P., Gupta, K. C., Sharma, M., & Kumar, S. (2024) · Springer eBooks · doi:10.1007/978-981-99-9404-5_14 · Cited by 5
Enterovirus infection, β-cell apoptosis and type 1 diabetes
Nair, S., Akil, A. A., & Craig, M. E. (2013) · Microbiology Australia · doi:10.1071/ma13051 · Cited by 2
Wood, J. F., Vergis, J. M., Imami, A. S., Ryan, W. G., Sin, J., Kim, B. J., Schiefer, I. T., & McCullumsmith, R. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157041 · Cited by 1
“Interestingly, previous studies have shown the LCK containing pathways are important for CVB viral replication in cardiac and immune cells [36].”
Posttranscriptional Gene Silencing
Ruppert, V., Pankuweit, S., Maisch, B., & Meyer, T. (2009) · Springer eBooks · doi:10.1007/978-3-540-77755-7_10 · Cited by 1
Caboxamycin with Antiviral Activity in CVB3-Induced Myocarditis Mouse ModelPreprint
Kim, H. G., Hillman, P. F., Lee, Y.-J., Jeon, H.-E., Lim, B., & Nam, S. (2023) · Preprints.org · doi:10.20944/preprints202309.2120.v1 · Cited by 1
Cellular and Immunological Regulation of Viral Myocarditis
Marchant, D., Farshid, S., & Bruce, M. (2011) · InTech eBooks · doi:10.5772/20845
“, 2002) and in vivo (Opavsky et al., 2002).”
BackgroundImmune Modulatory Therapies in Heart Failure: Using Myocarditis to Gain Mechanistic Insights
Chan, G. C., Fuse, K., Sun, M., Ayach, B., & Liu, P. P. (2006) · doi:10.1002/9780470994740.ch12
Self-citationThe Signaling Duel Between Virus and Host: Impact on Coxsackieviral Pathogenesis
Si, X., Marchant, D., Yang, D., McManus, B. M., & Luo, H. (2008) · Springer eBooks · doi:10.1007/978-0-387-09552-3_14
Viral Infection and Heart Disease
Rose, N. R., & Afanasyeva, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-444-63269-2.00026-x
Streptomyces Extract Inhibits Enterovirus 71 Replication by Activation of PKB/AKT Signaling
Jeong, B.-Y., Kim, H., & Lim, B. (2022) · Journal of Bacteriology and Virology · doi:10.4167/jbv.2022.52.3.094
“The inhibition of both signalings were completely blocked CVB3 replication in HeLa cells (11, 12).”
BackgroundAssociation between Histological Changes and Clinical Manifestations of Fulminant Myocarditis
Chen, C., & Wang, D. W. (2022) · Springer eBooks · doi:10.1007/978-981-19-5759-8_9
Trends in Meningitis Prevalence and the Need for Molecular Diagnosis
Baig, M. S., Rizvi, A. H., Varma, S., Ghaus, K., Arzoo, A., Saloni, & Anas, M. (2025) · Medical virology · doi:10.1007/978-981-96-7097-0_8 · Cited by 1
Coxsackievirus B regulates host circAKAP10 expression to promote viral replication
Li, Y., Wang, H., Liu, F., Liu, X., Zhang, M., Ji, Z., & Shen, H. (2025) · Archives of Virology · doi:10.1007/s00705-025-06348-9
“Our previous pharmacological studies confirm the feasibility of this approach, showing that blocking the ERK pathway effectively inhibits viral replication [ 3, 17].”
Cardiac tertiary immune niches drive immune activation in immune checkpoint inhibitor myocarditis
Tymm, C. C., Paiola, M., Bukhari, S., Hu, X., WINCHESTER, R. J., & Mor, A. (2026) · Science Advances · doi:10.1126/sciadv.aed8359
Metadata
- Authors
- Opavsky, M. A., Martino, T., Rabinovitch, M., Penninger, J., Richardson, C., Petric, M., Trinidad, C., Butcher, L., Chan, J., & Liu, P. P.
- Affiliations
- University Health Network (CA)
- Hospital for Sick Children (CA)
- University of Toronto (CA)
- Venue
- Journal of Clinical Investigation
- Published
- 2002-06-15
- Volume
- 109
- Issue
- 12
- Pages
- 1561-1569
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4231860860
- Cited by
- 91
- References
- 24
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2023: 1 · 2022: 5 · 2021: 6 · 2019: 1 · 2018: 3 · 2017: 2 · 2015: 4 · 2014: 1 · 2013: 4 · 2012: 5
- FWCI
- 4.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Funders
- Heart and Stroke Foundation of Canada
- University of Toronto
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- coxsackievirus B3, viral myocarditis, Lck, Src family kinases, A/J mice, C57BL/6 mice, cardiomyocytes, Jurkat cells, viral replication, UO126, PP2, MAPK signaling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.